Cargando…

Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells

The advent of induced pluripotent stem cells (iPSCs) together with recent advances in genome editing, microphysiological systems, tissue engineering and xenograft models present new opportunities for the investigation of hematological diseases and cancer in a patient-specific context. Here we review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Huensuk, Schaniel, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172418/ https://www.ncbi.nlm.nih.gov/pubmed/30323816 http://dx.doi.org/10.3389/fimmu.2018.02243

Ejemplares similares

Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome
por: Carvajal-Vergara, Xonia, et al.
Publicado: (2010)

Induced Pluripotent Stem Cell-Based Cancer Vaccines
por: Ouyang, Xiaoming, et al.
Publicado: (2019)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases
por: Tanaka, Takayuki, et al.
Publicado: (2022)

Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases
por: Li, Mailin, et al.
Publicado: (2017)

Induced pluripotent stem cells in hematology: current and future applications
por: Focosi, D, et al.
Publicado: (2014)

Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
por: Wattanapanitch, Methichit
Publicado: (2019)

Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges
por: Lu, Fei, et al.
Publicado: (2021)

Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
por: Tanaka, Atsushi, et al.
Publicado: (2015)

The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
por: Liu, Xin, et al.
Publicado: (2017)

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
por: Benabdallah, Basma, et al.
Publicado: (2019)

In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
por: Nikolouli, Eirini, et al.
Publicado: (2022)

Nitric oxide-mediated the therapeutic properties of induced pluripotent stem cell for paraquat-induced acute lung injury
por: Cui, Anfeng, et al.
Publicado: (2023)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
por: Tokuyama, Takeshi, et al.
Publicado: (2021)

Disease-specific pluripotent stem cells
por: Kang, Hoon-Chul
Publicado: (2010)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery
por: Jang, Jiho, et al.
Publicado: (2012)

The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development
por: Tsui, Michael, et al.
Publicado: (2021)

Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo
por: Roux, Clémence, et al.
Publicado: (2018)

Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids
por: Gaykema, Lonneke H., et al.
Publicado: (2023)

Patient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate models
por: Qiu, Zhifang, et al.
Publicado: (2013)

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
por: Pratumkaew, Ponthip, et al.
Publicado: (2021)

Induced pluripotent stem cell for modeling Pompe disease
por: Huang, Wenjun, et al.
Publicado: (2022)

Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy
por: Chhabra, Arvind
Publicado: (2017)

Modeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells
por: Jin, Zi-Bing, et al.
Publicado: (2011)

Modeling Transposition of the Great Arteries with Patient-Specific Induced Pluripotent Stem Cells
por: Ontoria-Oviedo, Imelda, et al.
Publicado: (2021)

Modeling diabetic endothelial dysfunction with patient‐specific induced pluripotent stem cells
por: Gorashi, Rayyan, et al.
Publicado: (2023)

Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141(+) Subset
por: Sachamitr, Patty, et al.
Publicado: (2018)

Patient-Specific Pluripotent Stem Cells in Neurological Diseases
por: Durnaoglu, Serpen, et al.
Publicado: (2011)

Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis
por: Lee, Jaecheol, et al.
Publicado: (2014)

Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated “Naïve-Like” Cells Capable of Restricting Mycobacteria Growth
por: Nenasheva, Tatiana, et al.
Publicado: (2020)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Influence of graft composition in patients with hematological malignancies undergoing ATG-based haploidentical stem cell transplantation
por: Zhang, Ran, et al.
Publicado: (2022)

Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
por: Eggenschwiler, Reto, et al.
Publicado: (2011)

Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies
por: Zaghi, Elisa, et al.
Publicado: (2019)

The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders
por: Cocks, Graham, et al.
Publicado: (2013)

Modeling congenital cataract in vitro using patient-specific induced pluripotent stem cells
por: Lyu, Danni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bj7g4cqeddeudiufssok5hcagr